Compared with the reference copeptin level (25.9 pmol/L), the prevalence of stroke increased with serum level of copeptin in a dose-response manner; however, no statistical significance was found for this increasing trend (Poverall = 0.139), as shown in Figure 1. The gene discussed is AVP; the disease is Stroke.